Reported Mar 9, 2022 · Terminated

Moxifloxacin Ophthalmic Solution USP 0.5%, 3 mL, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Dist. By…

Direct Rx

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Direct Rx · 94 Worldwide Dr · Dawsonville, GA · 30534-6828

Is this the product you have?

    • Moxifloxacin Ophthalmic Solution USP 0.5%
    • 3 mL
  • Packaged and Distributed By
    • Direct Rx Dawsonville
    • GA 30534 Dist. By Aurobindo Pharma USA
    • Inc. East Windsor
    • NJ 08520
    • NDC 72189-076-05
Lot codes and dates
    • Lot#: 18JA2218 Exp. 6/30/23
    • 20DE2104 Exp. 6/30/23
    • 08NO2111 Exp. 6/30/23
Amount recalled
44 bottles

Where it was sold

Why it was recalled

Failed impurities/degradation specifications

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Direct Rx recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Oct 4, 2023 · Data as of Sep 19, 8:05 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.